Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

New treatment option for severe Covid-19 ... coronavirus 2 infection. An international team of researchers led by Musa Khaitov at the Institute of Immunology (FBMA) in Moscow, working with Rudolf Valenta, Head of the Division of Immunopathology at MedUni Vienna's Institute of Pathophysiology and Allergy Research, has now developed a new drug that is inhaled and could prevent severe lung damage in Covid-19 patients. Valenta explains: "Only few treatments are currently available, among them the antibody cocktail from Regeneron, consisting of two antibodies, and the use of blood plasma. In this case virus-specific antibodies from support treatment... https://www.meduniwien.ac.at/web/en/ueber-uns/news/news-im-april-2021/neue-therapie-option-bei-schwerer-covid-19-erkrankung/medicine-science/
New treatment option for severe Covid-19 ... coronavirus 2 infection. An international team of researchers led by Musa Khaitov at the Institute of Immunology (FBMA) in Moscow, working with Rudolf Valenta, Head of the Division of Immunopathology at MedUni Vienna's Institute of Pathophysiology and Allergy Research, has now developed a new drug that is inhaled and could prevent severe lung damage in Covid-19 patients. Valenta explains: "Only few treatments are currently available, among them the antibody cocktail from Regeneron, consisting of two antibodies, and the use of blood plasma. In this case virus-specific antibodies from support treatment... https://www.meduniwien.ac.at/web/en/ueber-uns/news/news-im-april-2021/neue-therapie-option-bei-schwerer-covid-19-erkrankung/
Rudolf Valenta receives Immunology Leader Award ...All News – People of the MedUni Vienna (Vienna, 03-05-2023) Rudolf Valenta from Deptartment of Pathophysiology and Allergy Research at MedUni Vienna has been awarded the Immunology Leader Award by Research.com. In the ranking of the world's most cited scientists in the field of... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-may-2023/rudolf-valenta-receives-immunology-leader-award/people-of-the-meduni-vienna/
Rudolf Valenta receives Immunology Leader Award ...All News – People of the MedUni Vienna (Vienna, 03-05-2023) Rudolf Valenta from Deptartment of Pathophysiology and Allergy Research at MedUni Vienna has been awarded the Immunology Leader Award by Research.com. In the ranking of the world's most cited scientists in the field of... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-may-2023/rudolf-valenta-receives-immunology-leader-award/
Rudolf Valenta receives the EAACI’s Charles Blackley Award ...All News – People of the MedUni Vienna (Vienna, 24 June 2026) Rudolf Valenta of the Medical University of Vienna has been awarded the Charles Blackley Award by the European Academy of Allergy and Clinical Immunology (EAACI). The award was presented during the EAACI Congress 2026... https://www.meduniwien.ac.at/web/en/about-us/news/2026/news-in-june-2026/rudolf-valenta-receives-the-eaacis-charles-blackley-award/people-of-the-meduni-vienna/
Rudolf Valenta receives the EAACI’s Charles Blackley Award ...All News – People of the MedUni Vienna (Vienna, 24 June 2026) Rudolf Valenta of the Medical University of Vienna has been awarded the Charles Blackley Award by the European Academy of Allergy and Clinical Immunology (EAACI). The award was presented during the EAACI Congress 2026... https://www.meduniwien.ac.at/web/en/about-us/news/2026/news-in-june-2026/rudolf-valenta-receives-the-eaacis-charles-blackley-award/
News ... keine Möglichkeit festzustellen, welcher Antikörper notwendig wäre, um das jeweilige Rhinovirus zu bekämpfen. Das könnte nun mit einem an der MedUni Wien entwickelten Antikörper-Test gelingen. Im Rahmen des EU-Projekts „Predicta“ haben Rudolf Valenta, Leiter der Abteilung für Immunpathologie der MedUni Wien, und sein Team einen Rhinovirus-Chip entwickelt. „Erste Tests geben den Anlass zur Hoffnung, dass man damit durch Identifizierung der bei einem aktuellen Asthma- oder COPD-Anfall beteiligten Rhinoviren einen Impfstoff gegen Schnupfen entwickeln kann“, sagt Valenta. Analog zum ebenfalls im Team... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/impfung-gegen-schnupfen-ist-denkbar/
Prof. Oettgen: IgE and IgG antibodies in the regulation of immune responses in food allergy | MedUni Vienna ...All Events Allergy Research Programm:SFB Program Grant F46 "Towards prevention and therapy of allergy" Seminar Invitation“IgE and IgG antibodies in the regulation of immune responses in food allergy” Prof. Hans C. Oettgen, M.D., Ph.D.Children's Hospital Professor of Pediatric ImmunologyHarvard Medical SchoolAssociate Chief, Division of ImmunologyBoston Children’s Hospital Host: Rudolf Valenta Program   Download Flyer Share WhatsappFacebookLinkedInXingMailBlueSky All Events... https://www.meduniwien.ac.at/web/en/about-us/events/detail/prof-oettgen-ige-and-igg-antibodies-in-the-regulation-of-immune-responses-in-food-allergy/
Prof. Oettgen: IgE and IgG antibodies in the regulation of immune responses in food allergy | MedUni Wien ...Alle Events Allergy Research Programm:SFB Program Grant F46 "Towards prevention and therapy of allergy" Seminar Invitation“IgE and IgG antibodies in the regulation of immune responses in food allergy” Prof. Hans C. Oettgen, M.D., Ph.D.Children's Hospital Professor of Pediatric ImmunologyHarvard Medical SchoolAssociate Chief, Division of ImmunologyBoston Children’s Hospital Host: Rudolf Valenta Programm   Download Flyer Share WhatsappFacebookLinkedInXingMailBlueSky Alle Events... https://www.meduniwien.ac.at/web/ueber-uns/events/detail/prof-oettgen-ige-and-igg-antibodies-in-the-regulation-of-immune-responses-in-food-allergy/
It is getting personal: Precision diagnostics in cancer-specific immunotherapy | MedUni Vienna ...All Events We are pleased to announce thatProf. Hans Grönlund, Karolinska Institutet, Stockholm, SWEDEN will give a short seminar talk entitled"It is getting personal: Precision diagnostics in cancer-specific immunotherapy". The seminar will take place on Friday, May 17, 2024, at 12:30 p.m. in the Jugendstilhörsaal of Medical University, Vienna. We are looking forward seeing you there! Host: Prof. Rudolf Valenta Zur Einladung Share WhatsappFacebookLinkedInXingMailBlueSky All Events... https://www.meduniwien.ac.at/web/en/about-us/events/detail/it-is-getting-personal-precision-diagnostics-in-cancer-specific-immunotherapy/